Company: FLDDW
Filing Date: 2025-07-28
Form Type: S-1/A
Source: 0001213900-25-068264
Chunk: 357

Company: Fold Holdings, Inc.
Filing Date: 2025-07-28
Form: S-1/A
Chunk 357
---
 an Initial SPV Note with an aggregate principal amount of $20.0 million which is convertible to shares of our Common Stock. In conjunction with the SPV SPA and Initial SPV Investor Note, Fold also issued Series A, Series B, and Series C Warrants to the Investor (collectively with the Initial SPV Note, the “SPV Transaction”) for approximately 0.9 million, 0.5 million, and 0.9 million shares, respectively. The Series A Warrants are available for exercise for a period of eight years from December 24, 2024, at an exercise price of $12.50 per share. The Series B Warrants are available for exercise after the Business Combination date, for a period of eight years from December 24, 2024, at a nominal exercise price of $0.001 per share. On February 13, 2025, in connection with the closing of the Business Combination, the II-2 Investor exercised the Series B Warrants in full for 500,000shares of Common Stock. The Series C Warrants are available for exercise for a period of one year from the Closing, at an exercise price of $11.50 per share. The SVP SPA, the Initial SPV Note, the Series A and Series C Warrants were subsequently amended on June 16, 2025 — see paragraph (g) in this Item 15, below. (c) Senior Secured Convertible Promissory Note and Securities Purchase Agreement. On March 6, 2025, Fold entered into that certain Securities Purchase Agreement (the “SATS SPA”) between Fold and SATS Credit Fund, LP (“SATS Credit Fund”) pursuant to which SATS Credit Fund purchased an Initial Note with an aggregate principal amount of approximately $46.3 million which is convertible into an aggregate of approximately 3.7 million shares of Common Stock. In conjunction with the SATS SPA and SATS Note, Fold also issued a warrant for 925,590shares of Common Stock (the “SATS Warrant”). The SATS Warrant is exercisable in whole or in part at an exercise price of $15.00 per share. (d) Other Issuances. From January 1 to July 31, 2024, the Company entered into six SAFEs with various accredited investors, including Thesis Inc., a related party of the Company, with aggregate gross proceeds from these agreements totaling $71.1 million. All of the proceeds were